The characteristic features of Luminal A tumors include stage-1 disease, lymph node negativity, and well-differentiated cells, whereas those of Luminal B tumors include HER-2–positive nonluminal cancers with a high tumor grade, lymph-nodal metastases, robust proliferation, and advanced-stage disease [5]. Here, ERBB2 is linked to neoplasm.